Acquired Immunodeficiency Syndrome

• FDA approval · 2008-07-30
  FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)

  FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie.

• FDA approval · 2008-07-18
  FDA Approved: ZIAGEN — Supplemental Application (ViiV Healthcare Company)

  The FDA approved a supplemental application for ZIAGEN (abacavir sulfate) submitted by ViiV Healthcare Company.

• FDA approval · 2008-04-25
  FDA Approved: ZIDOVUDINE — Original Application (Camber Pharmaceuticals, Inc.)

  FDA approval of Camber Pharmaceuticals' generic Zidovudine under an original application for HIV infection treatment.

• FDA approval · 2007-07-31
  FDA Approved: VIRACEPT — Supplemental Application (AGOURON)

  The FDA approved a supplemental application for Viracept (nelfinavir mesylate) from Agouron Pharmaceuticals.

• FDA approval · 2006-11-15
  FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)

  FDA approved a supplemental application for RETROVIR (zidovudine) from ViiV Healthcare Company.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2006-11-15
  FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)

  The FDA approved a supplemental application for Retrovir (zidovudine) submitted by ViiV Healthcare Company.

• FDA approval · 2006-07-10
  FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)

  FDA approved a supplemental application for Retrovir (zidovudine) submitted by ViiV Healthcare Company.